Publisher(s):China Academic Journals (CD Edition) Electronic Publishing House Co., Ltd.
ISBN:ISBN 978-7-499-00980-6 pdf
First Published: 2020.11.23
Discipline(s): Medicine & Public Health
Price: $129 (for individuals) (中国大陆地区个人用户点此直接购买)
Institution users and community members, please click here to contact us.
Tumor (TCM), as part of China’s Medicine Progress Series, has 134 research articles on tumor treatment using TCM approaches. All the articles included are recommended by the editorial offices of the journals for the first publication. The book contains sections of Anti-tumor Advances in TCM, Analysis of Effective Components, Respiratory System Tumor, Urogenital Tumor, and Digestive System Tumor, with mechanism explanation and clinical research involved. Supported by scientific methodology, it fully demonstrates the unique approaches and excellent therapeutic effects of TCM, with objective findings concluded. This book is a compilation of the English version of the articles originally published in Chinese.
LIU Changxiao is the honorary president, tenured principal scientist and academic committee director of Tianjin Institute of Pharmaceutical Research, and the director of the State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, the Center
Liaoning Journal of Traditional Chinese Medicine,Part 1: Anti-tumor Advances in TCM,Vol 43,No. 01
Objective: To analyze and evaluate the status of malignant tumor in traditional Chinese medicine to provide practical and effective suggestions for clinical workers. Methods: The literature on the published in recent 20 years about the treatment of malignant tumor with traditional Chinese medicine in the core magazines, including the summary classification of clinical research reports, etc. Results: All physicians on malignant tumor drug treatment is not the same, but can be divided into four methods: strengthening the body resistance to eliminate pathogenic factors, eliminating toxin by poisonous drugs, clearing heat and detoxicating, promoting blood circulation and removing blood stasis. Conclusion: Syndrome differentiation is the core in clinic and strengthening the vital Qi as the treatment principle can achieve the best effect.
Chinese Archives of Traditional Chinese Medicine,Part 1: Anti-tumor Advances in TCM,Vol 35,No. 02
Angiogenesis is the basis of cancer metastasis and growth. Anti-angiogenesis therapy has become conventional treatment for colorectal cancer. Researches have shown that Chinese herbal compounds including tanshinone IIA, norcantharidin and solanine, Chinese herbs such as Oldenlandia diffusa, Scutellaria barbata and Pulsatilla chinensis, and Chinese herbal formulae including Jianpi Jiedu Fang, Jianpi Xiaoai-Fang and Tenglong Buzhong Decoction can inhibit angiogenesis in colorectal cancer. On this basis, it is of great significance to further explore the Chinese herbal medicine resources, and develop highly effective and low-toxic Chinese medicine preparations aimed at anti-angiogenesis in the treatment of colorectal cancer.
3. Impacts of moxibustion at Zusanli (ST 36) on the improvements in the quality of life in patients with advanced malignant tumor
Chinese Acupuncture & Moxibustion,Part 1: Anti-tumor Advances in TCM,Vol 39,No. 03
Objective To observe the impacts of moxibustion at Zusanli (ST 36) on the improvements in the quality of life in the patients with advanced malignant tumor. Methods A total of 60 patients with advanced malignant tumor were randomized into an observation group and a control group, 30 cases in each one. In the control group, the routine symptomatic scheme was adopted. In the observation group, on the base of the routine treatment, moxibustion was applied to bilateral Zusanli (ST 36), once a day. The observation period was 12 days. The percentages of CD 3 +, CD 4 + and CD 8 + in T lymphocyte subset, the ratio of CD 4 +/CD 8 +, the value of hemoglobin, Karnofsky (KPS) score and the main symptom score of traditional Chinese medicine (TCM) were compared before and after treatment in the two groups. Results In comparison before and after treatment in the two groups as well as between the two groups, the differences were not significant in the contents of CD + 3, CD + 4 and CD + 8, hemoglobin and the ratio of CD + 4/CD + 8 (all P > 0.05). In the observation group, KPS after treatment was increased as compared with the score before treatment ( P < 0.05). In the observation group, the scores of the main TCM symptoms, i. e., lassitude, insomnia, poor appetite, spontaneous sweating, dizziness and vertigo as well as the total score after treatment were all reduced as compared with the scores before treatment (all P < 0.01). In the control group, the difference was not significant in the score of each item (all P > 0.05). In the observation group, the improvements in lassitude, short breath, poor appetite, dizziness and vertigo, complexion, palpitation, soreness and weakness of the lumber region and knee joint as well as the total score were better than the control group ( P < 0.05, P < 0.01). Conclusion Moxibustion at Zusanli (ST 36) effectively regulates the immune balance and relieves the clinical symptoms in the patients with advanced malignant tumor.
4. Review on Traditional Chinese Medicine Therapies for Bone Marrow Suppression after Radiotherapy and Chemotherapy for Breast Cancer
World Chinese Medicine,Part 1: Anti-tumor Advances in TCM,Vol 14,No. 04
With the development of society, the incidence of breast cancer is increasing year by year, and radiotherapy and chemotherapy have been recognized as effective methods for the treatment of breast cancer. However, the radiotherapy and chemotherapy will induce adverse reactions such as bone marrow suppression in patients, which has not only seriously affected the process of radiotherapy and chemotherapy, but also made patients lose the confidence to overcome the cancer due to the deterioration of their physical conditions. In recent years, a large number of clinical reports have demonstrated that the intervention with traditional Chinese medicine improves the clinical efficacy, patient’s response to bone marrow suppression, as well as their quality of life after radiotherapy and chemotherapy, thereby enhancing their confidence in overcoming the disease. By reviewing the literature reports in the past 10 years, we have screened out some of the traditional Chinese medicine treatments with good efficacy for bone marrow suppression caused by radiotherapy and chemotherapy for breast cancer, hoping to provide some reference for clinicians.
5. Review on Traditional Chinese Medicine Therapies for Chemotherapy-induced Fatigue After Breast Cancer Surgery
World Chinese Medicine,Part 1: Anti-tumor Advances in TCM,Vol 14,No. 05
Chemotherapy-induced fatigue after breast cancer surgery is one of the clinical symptoms bothering cancer patients, which has seriously affected their quality of life. The traditional Chinese medicine therapies have a promising prospect due to little side effect, high safety, and good compliance. In recent years, the application of traditional Chinese medicine in the treatment of chemotherapy-induced fatigue after breast cancer surgery has been extensively studied, and it has aroused more and more attention. In this paper, by collecting and sorting out related articles available in Chongqing Weipu Database for Chinese Technical Periodicals (VIP), China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, Pub Med and Cochrane Library databases, we summarized the basic and clinical research progress in China and abroad of the past 10 years on TCM intervention in chemotherapy-induced fatigue after breast cancer surgery, followed by objective evaluation of the efficacy of traditional Chinese medicine in treating such disease, and preliminary analysis of its action mechanism. At the same time, we have also pointed out the problems existed in clinical trails, which need to be further standardized and studied in the future.